Design Therapeutics
DSGN
DSGN
74 hedge funds and large institutions have $542M invested in Design Therapeutics in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
12% less capital invested
Capital invested by funds: $614M → $542M (-$72.1M)
Holders
74
Holding in Top 10
3
Calls
$2.68M
Puts
–
Top Buyers
| 1 | +$5.45M | |
| 2 | +$4.8M | |
| 3 | +$3.68M | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$2.94M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$1.61M |
Top Sellers
| 1 | -$8.31M | |
| 2 | -$3.23M | |
| 3 | -$3.09M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.66M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$808K |